CEMPRA PHARMACEUTICALS INC

Pharmaceutical company

Active 2007–2017. The register lists this client once for every firm that files on its behalf; all 3 of its records are shown together here.

Filings
30
Filed By
3
Reported In-House
—
Reported By Firms
$690,000

Filings

YearFirmPeriodAmountDoc
2017 THE CONAFAY GROUP, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$20,000
2017 THE CONAFAY GROUP, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2017 THE CONAFAY GROUP, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2017 THE CONAFAY GROUP, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$60,000
2016 THE CONAFAY GROUP, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$40,000
2016 POLSINELLI PC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination (No Activity)
$20,000
2016 THE CONAFAY GROUP, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2016 POLSINELLI PC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2016 THE CONAFAY GROUP, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$20,000
2016 POLSINELLI PC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$20,000
Page 1 of 3  ·  30 filings Next
Filed By
FirmFilingsAmount
THE CONAFAY GROUP, LLC 15 $380,000
POLSINELLI PC 10 $220,000
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 5 $90,000
Issue Areas

Bills Mentioned in Filings